What is the market cap difference between LLY and NVO?

LLY has a market cap of $880.0B and NVO has a market cap of $173.7B. LLY has a 5.1x larger market capitalization than NVO

LLY vs NVO Stock Comparison

Compare Eli Lilly and Company (LLY) and Novo Nordisk A/S (NVO) side by side. View price, valuation, dividends, and financial metrics.

Eli Lilly and Company

$981.11-2.02%

Healthcare / Drug Manufacturers - General · $880.0B market cap

Novo Nordisk A/S

$39.10+1.48%

Healthcare / Drug Manufacturers - General · $173.7B market cap

Both LLY and NVO operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.

LLY has a 5.1x larger market capitalization than NVO.

NVO trades at a lower P/E ratio (11.1x) compared to LLY (44.4x), suggesting NVO may be more attractively valued relative to its earnings.

NVO offers a higher dividend yield (3.15%) vs LLY (0.70%), making it more attractive for income investors.

Looking at profitability, LLY has a profit margin of 3166.4% while NVO's is 3302.7%. NVO converts more of its revenue into profit.

In terms of growth, LLY has revenue growth of 42.6% versus 643.0% for NVO. NVO is growing its top line faster.

Which is a better investment, LLY or NVO?: Both stocks have different strengths. Eli Lilly and Company (LLY) trades at $981.11 with a $880.0B market cap, while Novo Nordisk A/S (NVO) trades at $39.10 with a $173.7B market cap. NVO trades at a lower P/E ratio (11.1x) compared to LLY (44.4x), suggesting NVO may be more attractively valued relative to its earnings. The better choice depends on your investment goals, time horizon, and risk tolerance.
Are LLY and NVO in the same sector?: Both LLY and NVO operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.
Do LLY and NVO pay dividends?: NVO offers a higher dividend yield (3.15%) vs LLY (0.70%), making it more attractive for income investors.